Read Medical News and Updates, Conference Reports

Filter by Specialty:

Multidisciplinary

Cardiology

Dermatology

Endocrinology

Gastroenterology

Hepatology

Infectious Diseases

Neurology

Obstetrics & Gynaecology

Oncology

Ophthalmology

Paediatrics

Psychiatry

Respirology

Rheumatology

Urology

Pharmacy

Multidisciplinary

Cardiology

Dermatology

Endocrinology

Gastroenterology

Hepatology

Infectious Diseases

Neurology

Obstetrics & Gynaecology

Oncology

Ophthalmology

Paediatrics

Psychiatry

Respirology

Rheumatology

Urology

Pharmacy

Specialty:

Multidisciplinary

Cardiology

Dermatology

Endocrinology

Gastroenterology

Hepatology

Infectious Diseases

Neurology

Obstetrics & Gynaecology

Oncology

Ophthalmology

Paediatrics

Psychiatry

Respirology

Rheumatology

Urology

Pharmacy

Latest Medical News

Special Reports

Have you got your "Eye on AAO?" Download the 2017 e-bulletins here

25 Jul 2024

Towards successful management of allergic rhinitis and advocating for a paradigm shift

Earlier initiation of dual therapy, cardiorenal protection new targets of T2DM management

Vonoprazan in Focus: Advancing Gastrointestinal Therapy Beyond Proton Pump Inhibitors

New study findings show significant rise in Hb levels in 14 days, symptom relief in 30 days & improved quality of life in women with Iron Deficiency Anaemia

Debunking the myths about DPP-4 inhibitors

Optimising Treatment in Myelofibrosis, Considerations for Ruxolitinib Resistance

SGLT-2i – The standard of care, first-line treatment for patients with T2DM and CKD

The role of oral anticoagulant with direct thrombin inhibition in atrial fibrillation

Have you got your "Eye on AAO?" Download the 2017 e-bulletins here

Towards successful management of allergic rhinitis and advocating for a paradigm shift

Earlier initiation of dual therapy, cardiorenal protection new targets of T2DM management

Vonoprazan in Focus: Advancing Gastrointestinal Therapy Beyond Proton Pump Inhibitors

New study findings show significant rise in Hb levels in 14 days, symptom relief in 30 days & improved quality of life in women with Iron Deficiency Anaemia

Debunking the myths about DPP-4 inhibitors

Optimising Treatment in Myelofibrosis, Considerations for Ruxolitinib Resistance

SGLT-2i – The standard of care, first-line treatment for patients with T2DM and CKD

Conference Reports

Norovirus a growing threat that remains under-recognized

30 Jul 2024

ACOG article 2.3

27 Jul 2024

Comprehensive evaluation a must in paediatric hypertension

26 Jul 2024

Routine hypertension screening in paediatrics debatable

26 Jul 2024

Gatekeeping model central to primary care across region

26 Jul 2024

Lower all-cause death, fewer HF events with empagliflozin in acute HF

25 Jul 2024

Read the latest news in the Medical industry

Filter by Specialty:

Specialty:

Latest Medical News

Norovirus a growing threat that remains under-recognized

ACOG article 2.3

Comprehensive evaluation a must in paediatric hypertension

Routine hypertension screening in paediatrics debatable

Gatekeeping model central to primary care across region

Lower all-cause death, fewer HF events with empagliflozin in acute HF

Special Reports

Have you got your "Eye on AAO?" Download the 2017 e-bulletins here

Towards successful management of allergic rhinitis and advocating for a paradigm shift

Earlier initiation of dual therapy, cardiorenal protection new targets of T2DM management

Vonoprazan in Focus: Advancing Gastrointestinal Therapy Beyond Proton Pump Inhibitors

New study findings show significant rise in Hb levels in 14 days, symptom relief in 30 days & improved quality of life in women with Iron Deficiency Anaemia

Debunking the myths about DPP-4 inhibitors

Optimising Treatment in Myelofibrosis, Considerations for Ruxolitinib Resistance

SGLT-2i – The standard of care, first-line treatment for patients with T2DM and CKD

The role of oral anticoagulant with direct thrombin inhibition in atrial fibrillation

Have you got your "Eye on AAO?" Download the 2017 e-bulletins here

Towards successful management of allergic rhinitis and advocating for a paradigm shift

Earlier initiation of dual therapy, cardiorenal protection new targets of T2DM management

Vonoprazan in Focus: Advancing Gastrointestinal Therapy Beyond Proton Pump Inhibitors

New study findings show significant rise in Hb levels in 14 days, symptom relief in 30 days & improved quality of life in women with Iron Deficiency Anaemia

Debunking the myths about DPP-4 inhibitors

Optimising Treatment in Myelofibrosis, Considerations for Ruxolitinib Resistance

SGLT-2i – The standard of care, first-line treatment for patients with T2DM and CKD

Conference Reports

Norovirus a growing threat that remains under-recognized

ACOG article 2.3

Comprehensive evaluation a must in paediatric hypertension

Routine hypertension screening in paediatrics debatable

Gatekeeping model central to primary care across region

Lower all-cause death, fewer HF events with empagliflozin in acute HF